AURKA and hepatocellular carcinoma: Aurora kinase A (AURKA), a family member of mitotic serine/threonine kinases, provides stability to Myc protein by directly binding to it and inhibition of this protein–protein interaction using novel AURKA inhibitor, MLN8237 has shown promising results in HCC [150,151].